Sahar Elouej1,2, Hanen Belfki-Benali3, Majdi Nagara1,2, Khaled Lasram1,2, Redha Attaoua4, Om Kalthoum Sallem1,5, Ines Kamoun6, Mariem Chargui1, Lilia Romdhane1, Henda Jamoussi1,5, Zinet Turki6, Abdelmajid Abid1,5, Claude Ben Slama6, Sonia Bahri2,7, Sonia Abdelhak1,2, Florin Grigorescu4, Habiba Ben Romdhane3, Rym Kefi1,2. 1. 1 Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis , Tunis, Tunisia . 2. 2 Faculté des Sciences de Tunis, Université de Tunis El Manar , El Manar I Tunis, Tunisia . 3. 3 Cardiovascular Epidemiology and Prevention Research Laboratory, Faculty of Medicine , Tunis, Tunisia . 4. 4 Molecular Endocrinology Laboratory, IURC , Montpellier, France . 5. 5 Department of External Consultation, National Institute of Nutrition and Food Technology , Tunis, Tunisia . 6. 6 Department of Endocrinology and Metabolic Diseases, National Institute of Nutrition , Tunis, Tunisia . 7. 7 Laboratoire Central de Biologie Médicale, Institut Pasteur de Tunis , Tunis, Tunisia .
Abstract
BACKGROUND: Variants in the fat mass and obesity-associated (FTO) gene are associated with obesity and type 2 diabetes mellitus. AIM OF THE STUDY: This study aims to assess the association of the rs9939609 variant and haplotypes in FTO gene with metabolic syndrome (MetS) components in a Tunisian population sample. METHODS: A total of 685 Tunisian subjects were genotyped for the rs9939609T>A using TaqMan allelic discrimination assay. Two variants rs1421085T>C and rs8057044A>G already genotyped in a previous study were used to test haplotype association of the FTO gene. RESULTS: Genotype distribution of the variant rs9939609 was different between MetS and controls (P = 0.017). Individuals carrying TA genotypes had a significantly increased risk independently of body mass index or age (P = 0.009). The variant rs9939609 was also associated with impaired fasting glucose (IFG) (P = 0.002). Among the eight haplotypes in the population, the haplotype GCA was significantly associated with a higher risk of developing the MetS, higher systolic blood pressure, and higher levels of fasting glucose and triglycerides (TGs) in the total sample and females, separately. Separate analysis by gender revealed a protective haplotype TGT among women (P = 0.023). CONCLUSIONS: FTO haplotypes have a strong influence on blood pressures and TG and IFG levels. These findings provide evidence that FTO gene may play a critical role in leading to MetS in Tunisian population.
BACKGROUND: Variants in the fat mass and obesity-associated (FTO) gene are associated with obesity and type 2 diabetes mellitus. AIM OF THE STUDY: This study aims to assess the association of the rs9939609 variant and haplotypes in FTO gene with metabolic syndrome (MetS) components in a Tunisian population sample. METHODS: A total of 685 Tunisian subjects were genotyped for the rs9939609T>A using TaqMan allelic discrimination assay. Two variants rs1421085T>C and rs8057044A>G already genotyped in a previous study were used to test haplotype association of the FTO gene. RESULTS: Genotype distribution of the variant rs9939609 was different between MetS and controls (P = 0.017). Individuals carrying TA genotypes had a significantly increased risk independently of body mass index or age (P = 0.009). The variant rs9939609 was also associated with impaired fasting glucose (IFG) (P = 0.002). Among the eight haplotypes in the population, the haplotype GCA was significantly associated with a higher risk of developing the MetS, higher systolic blood pressure, and higher levels of fasting glucose and triglycerides (TGs) in the total sample and females, separately. Separate analysis by gender revealed a protective haplotype TGT among women (P = 0.023). CONCLUSIONS:FTO haplotypes have a strong influence on blood pressures and TG and IFG levels. These findings provide evidence that FTO gene may play a critical role in leading to MetS in Tunisian population.